In the latest development in the high-profile dispute over Merck’s losses from 2017’s NotPetya cyber attack, insurers have hit back at the pharmaceutical giant’s argument that the court should treat its claim for more than $1.3bn as uncontested.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: